Cristiana
Cristiana Balocchi, Siena IT
Patent application number | Description | Published |
---|---|---|
20130196352 | BACTERICIDAL ANTIBODY ASSAYS TO ASSESS IMMUNOGENICITY AND POTENCY OF MENINGOCOCCAL CAPSULAR SACCHARIDE VACCINES - The disclosure provides compositions, methods and kits for assessing immunogenicity, potency, or both, of meningococcal capsular saccharide vaccines. The assessment is based upon measurement of binding of a bactericidal antibody to a capsular saccharide component in the vaccine. | 08-01-2013 |
Cristiana Carniti, Milan IT
Patent application number | Description | Published |
---|---|---|
20150231198 | COMBINATION THERAPY FOR HEMATOLOGICAL MALIGNANCIES - Methods of treating, preventing or managing T-cell lymphomas are disclosed. The methods encompass administration of an HDAC inhibitor romidepsin and an alkylating agent bendamustine, also known as TREANDA®. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods provided herein are also disclosed | 08-20-2015 |
Cristiana Da Silva Oliveira Paulo, Cantanhede PT
Patent application number | Description | Published |
---|---|---|
20130216600 | ANTIMICROBIAL NANOPARTICLE CONJUGATES - The present invention provides antimicrobial nanoparticle conjugates and an efficient method of preparing same. In particular, the invention relates to the preparation of antifungal nanoparticle conjugates comprising amphotericin B covalently immobilized to nanoparticles. The conjugates, and suspensions thereof, can be used to form antifungal coatings with particular application to medical devices and materials. | 08-22-2013 |
Cristiana Dimitriu, Teaneck, NJ US
Patent application number | Description | Published |
---|---|---|
20120077527 | NETWORK EVENT IDENTIFICATION AND METHOD OF OPERATION - A method and apparatus for detecting events in an electrical network is provided. The method and apparatus measure a plurality of electrical parameters on the electrical network. A precursor event is detected. The measured parameters are captured and analyzed. The precursor event is categorized and a plurality of notifications having integrated data related to the event are electronically transmitted. | 03-29-2012 |
Cristiana Gassmann-Mayer, Pennington, NJ US
Patent application number | Description | Published |
---|---|---|
20110105536 | DOSING REGIMEN ASSOCIATED WITH LONG-ACTING INJECTABLE PALIPERIDONE ESTERS - The present application provides a method for treating patients in need of psychiatric treatment, wherein said patient misses a stabilized dose of a monthly maintenance regimen of paliperidone palmitate. The present application also provides a method for treating psychiatric patients in need of a switching treatment to paliperidone palmitate in a sustained release formulation. | 05-05-2011 |
Cristiana Guiducci, Albany, CA US
Patent application number | Description | Published |
---|---|---|
20090131512 | Inhibition of type I in IFN production - The invention provides methods for decreasing type I IFN production by human plasmacytoid dendritic cells in response to TLR activation. | 05-21-2009 |
20110003885 | METHODS AND COMPOSITIONS FOR INHIBITION OF IMMUNE RESPONSES AND AUTOIMMUNITY - The application relates to the use of immunoregulatory polynucleotides and/or immunoregulatory compounds in combination with other therapeutic agents. The application further relates to immunoregulatory polynucleotides and/or immunoregulatory compounds comprising a modified immunoregulatory sequence. It also relates to the administration of the immunoregulatory polynucleotides and/or immunoregulatory compounds comprising a modified immunoregulatory sequence to regulate an immune response. | 01-06-2011 |
20120252051 | TLR8 TRANSGENIC ANIMALS - Provided herein are human Toll-like receptor 8 (TLR8)-expressing transgenic animals and methods of use thereof. | 10-04-2012 |
20130156814 | METHODS OF TREATMENT USING TLR7 AND/OR TLR9 INHIBITORS - The application relates to compositions and methods of regulating an immune response comprising inhibitors of TLR7 and/or TLR9, such as immunoregulatory polynucleotides and/or immunoregulatory compounds. The application also relates to compositions and methods for predicting and/or determining responsiveness of a disease to treatment comprising inhibitors of TLR7 and/or TLR9. | 06-20-2013 |
20140094504 | HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF - Provided herein are human Toll-like receptor (TLR)-inhibitors and methods for use in individuals having an autoimmune disease or an inflammatory disorder. The TLR inhibitors of the present disclosure are polynucleotides comprising an inhibitory motif for one or more of TLR7, TLR8 and TLR9. | 04-03-2014 |
20150203850 | METHODS OF TREATMENT USING TLR7 AND/OR TLR9 INHIBITORS - The application relates to compositions and methods of regulating an immune response comprising inhibitors of TLR7 and/or TLR9, such as immunoregulatory polynucleotides and/or immunoregulatory compounds. The application also relates to compositions and methods for predicting and/or determining responsiveness of a disease to treatment comprising inhibitors of TLR7 and/or TLR9. | 07-23-2015 |
Cristiana Mollinari, Rome IT
Patent application number | Description | Published |
---|---|---|
20110123499 | CELLULAR DIFFERENTIATION PROMOTION - Neural precursor cells can be encouraged to form mature neural cells twice as quickly in the absence, or reduced expression of, thymosin β4. | 05-26-2011 |
Cristiana Scaramel, Novi Ligure IT
Patent application number | Description | Published |
---|---|---|
20090080131 | DEVICE FOR PROTECTING ELECTRONIC CIRCUITS AGAINST FAULTS - A protection device for protecting an electronic circuit against a fault is described. The electronic circuit includes an output stage for driving a load and a driving circuit for driving the output stage. The driving circuit is configured to produce a drive signal in response to at least one input signal. The protection device includes a gating circuit and control means. The gating circuit has a first input configured to receive the drive signal, a second input configured to receive a control signal, and an output configured to activate and deactivate the output stage based on the drive signal and control signal. The control means produce the control signal in response to a detection signal representative of detection of the fault either of the load or of the output stage. | 03-26-2009 |
Cristiana Soldani, Milano IT
Patent application number | Description | Published |
---|---|---|
20090263544 | CONFECTIONERY PRODUCT - Hard candy which includes at least one acidic component and which shows improved transparency is made by forming a liquid starting material comprising at least one sugar alcohol which is not a monosaccharide sugar alcohol, water, and the acidic component; heating under conditions at which the acidic component does not cause significant hydrolysis of the sugar alcohol to dissolve the acidic component in the liquid and remove at least part of the water; and cooling to form the hard candy. The product has a transmission of: at least 47.8% at 450 mnm; and/or at least 50.9% at 550 nm; and/or at least 52.3% at 650 nm. | 10-22-2009 |